Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 2963-2967

  Choi, S H ^a   Chung, J W ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; NAFCILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM EXAMINATION; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE DURATION; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; FOLLOW UP POSITIVE BLOOD CULTURE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL PARAMETERS; MORTALITY; PATIENT CARE; PERSISTENT INFECTION; PRIORITY JOURNAL; SECONDARY INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TIME TO BLOOD CULTURE POSITIVITY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; FEMALE; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867994146     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1648-0     Document Type: Article

References (12)

1. Khatib R, Riederer K, Saeed S, Johnson LB, Fakih MG, Sharma M, Tabriz MS, Khosrovaneh A (2005) Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 41:594-598
2. Kim J, Gregson DB, Ross T, Laupland KB (2010) Time to blood culture positivity in Staphylococcus aureus bacteremia: Association with 30-day mortality. J Infect 61:197-204
3. Lai CC, Wang CY, Liu WL, Huang YT, Hsueh PR (2011) Time to blood culture positivity as a predictor of methicillin resistance in Staphylococcus aureus bacteremia. J Infect 62:190-191
4. Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman GML (2006) Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol 44:1342-1346
5. Liao CH, Huang YT, Chu FY, Lin TH, Hsueh PR (2008) Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy. J Microbiol Immunol Infect 41:355-357
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633-638
7. Passerini R, Riggio D, Radice D, Bava L, Cassatella C, Salvatici M, Zorzino L, Sandri MT (2009) Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncology hospital. Eur J Clin Microbiol Infect Dis 28:95-98
8. Fowler VG, Sakoulas G, Mclntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS (2004) Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis 190:1140-1149
9. Hawkins C, Huang J, Jin N, Noskin GA, Zembower TR, Bolon M (2007) Persistent Staphylococcus aureus bacteremia. Arch Intern Med 167:1861-1867
10. Khatib R, Johnson LB, Fakih MG, Riederer K, Khosrovaneh A, Tabriz MS, Sharma M, Saeed S (2006) Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand J Infect Dis 38:7-14
11. Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR (2010) Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. J Antimicrob Chemother 65:1792-1798
12. Yoon YK, Kim JK, Park DW, Sohn JW, Kim MJ (2010) Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65:1015-1018